Infusion
A medicine given slowly through a drip into a vein, usually in hospital.
Also called: iv, intravenous, intravenous infusion, drip, infusion unit
Related words subcutaneous injection
A medicine given slowly through a drip into a vein, usually in hospital.
Also called: iv, intravenous, intravenous infusion, drip, infusion unit
Related words subcutaneous injection
Upadacitinib is a tablet that belongs to a group called JAK inhibitors. It blocks proteins inside cells that switch on the immune response, rather than being an antibody given by drip or injection. Trials found it worked better than placebo for moderate to severe Crohn's, and NICE recommends it after a biologic has failed or when anti-TNFs are unsuitable. Shingles was more common in people taking it.
Sources
Crohn's & Colitis UK explains that biologics are antibody medicines made by living cells in a lab. Each one targets a specific part of the immune system involved in inflammation: anti-TNFs (infliximab, adalimumab), the anti-integrin vedolizumab, and interleukin blockers (ustekinumab, risankizumab, mirikizumab, guselkumab). They are given by drip or by injection under the skin. Upadacitinib is a 'targeted' tablet, not a biologic.
Sources
Crohn's & Colitis UK says iron deficiency anaemia is common in Crohn's, caused by blood loss from the gut, poor absorption or too little iron in the diet. Symptoms include tiredness, breathlessness, headaches and pale skin, says the NHS. Treatment may be iron tablets or iron given into a vein; a Cochrane review found iron through a drip probably helps more people than tablets.
Sources
A guide to infliximab, an anti-TNF biologic given by drip or as an injection under the skin. It lists the original brand Remicade and biosimilars such as Remsima, Inflectra, Flixabi and Zessly, and explains checks before starting, that your team may measure drug and antibody levels in your blood, and possible side effects.
Topics Biologics and newer medicines Monitoring
Jargon explained anti-TNF infusion subcutaneous biosimilar drug levels antibodies
A guide to vedolizumab (Entyvio), which starts as a drip into a vein and may later be switched to injections under the skin. It covers how it works on the gut, trial results and side effects.
Topics Biologics and newer medicines
Jargon explained integrin intravenous infusion subcutaneous injection
A patient leaflet for people starting a biologic for IBD. It explains what biologics are, when they are used (often after steroids or azathioprine have not worked), and lists the biologics used at the hospital, their brands and how each is given.
Topics Biologics and newer medicines
Jargon explained biologic infusion biosimilar
Looks at iron tablets and iron drips for anaemia caused by low iron in IBD. The reviewers found the evidence too weak to say for certain which works best, even though both are widely used and guidelines favour drips. They highlight this as an important gap.
Jargon explained iron deficiency anaemia intravenous iron ferric carboxymaltose
The BSG guideline on iron deficiency anaemia. It explains that the gut is a common source of the blood loss or poor absorption behind it, and that good care means both replacing iron (by mouth or drip) and finding the cause.
Topics Anaemia Diagnosis and tests
Jargon explained iron deficiency anaemia intravenous iron
The British Association for Parenteral and Enteral Nutrition, the UK body that works on malnutrition. It provides resources on spotting and screening for malnutrition and on nutritional care, including tube and drip feeding.
Topics Diet and nutrition
Jargon explained malnutrition enteral nutrition parenteral nutrition MUST screening
Describes a hospital clinical psychology team for children and young people with IBD and their families. It can help with adjusting to diagnosis, worries about injections, infusions or surgery, telling friends, and coping with pain, fatigue and bowel symptoms.
Topics Children and young people Mental health
Jargon explained clinical psychologist paediatric
The trials that led to ustekinumab (Stelara) being used for Crohn's. A first drip of ustekinumab helped more people improve than a dummy drip, and injections every 8 or 12 weeks afterwards kept about half of responders in remission at week 44, against about 36% on placebo. Side effects were similar between groups.
Topics Biologics and newer medicines
Jargon explained induction maintenance IL-12/23 placebo
A guide to guselkumab (Tremfya), an IL-23 blocking medicine. The first three doses can be a drip or an injection, after which it is injected under the skin; the page covers vaccines and side effects.
Topics Biologics and newer medicines
Jargon explained IL-23 interleukin inhibitor
A guide to mirikizumab (Omvoh), a biologic that blocks the IL-23 protein. It explains the starting doses by drip followed by injections under the skin if it works, vaccine advice, and side effects.
Topics Biologics and newer medicines
Jargon explained IL-23 interleukin inhibitor non-live vaccine
A guide to risankizumab (Skyrizi), a biologic that blocks the IL-23 protein involved in inflammation. You start with a few drips, then have regular injections under the skin; the page explains trial results and side effects.
Topics Biologics and newer medicines
Jargon explained IL-23 interleukin biologic
A guide to ustekinumab, an interleukin inhibitor that blocks IL-12 and IL-23. Stelara was the first brand and several biosimilars now exist. The first dose is a drip, then injections under the skin; the page covers trial results and side effects.
Topics Biologics and newer medicines
Jargon explained interleukin inhibitor IL-12 IL-23 biosimilar